Review of Dohan Eherenfest et al. (2009) on “Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)”

Fermín, Theodorakys Marín; Calcei, Jacob G.; Vedova, Franco Della; Cano, Juan Pablo Martínez; Calderon, Claudia Arias; Imam, Mohamed A.; Khoury, Miguel; Laupheimer, Markus W.; D’Hooghe, Pieter

doi:10.1016/j.jisako.2023.07.010

Cited by 6 publications

(2 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In 2009, the working group of Dohan Eherenfest suggested four categories of platelet concentrates (P-PRP, L-PRP, P-PRF, and L-PRF), as an attempt to use categorized and standardized PDPs. Furthermore, this claim promoted scientific research to understand and explain the intrinsic biochemical proprieties of PDPs, assuming the demanding need to validate their use, in clinical settings [93]. In 2012, the group of DeLong presented their classification PAW system, based on the report of three constituents in PRP preparation: number of platelets, platelet activation method, and the presence or absence of white blood cells [94].…”

Section: The Boundaries Of Platelet Therapy: Mandatory Use Of Standar...mentioning

confidence: 99%

Regenerative Medicine in the Treatment of Traumatic Skin Wounds in Dogs and Cats Using Platelet-Rich Fibrin (PRF) Therapy

S. Soares,

P. Carvalho,

dos Anjos Pires

2024

Pearls in Biological and Molecular Tissue Repair Pathways

View full text Add to dashboard Cite

Regenerative medicine has gained prominence in recent decades and originated from the growing need for medical intervention in degenerative diseases associated with age. This need is believed to be enhanced also by the increase in the average life expectancy of pets, aliased with the growing social integration of pets into human lives, and the development of specialized veterinary medical care. Platelet-rich products, such as platelet-rich fibrin (PRF), have received attention in clinical veterinary settings. PRF therapy has been proposed for the treatment of skin wounds of various etiologies. Traumatic skin wounds are a frequent occurrence in veterinary practice, constituting an opportunity for PRF therapy application, as an adjunct to medical and surgical treatments. The PRF biomaterial is a hemoderivative obtained after single whole-blood centrifugation. In the process, platelets and leukocytes are activated, resulting in a fibrin clot rich in growth factors and cytokines. Considering the young age of PRF regenerative therapy, it is imperative to promote well-characterized PRF biomaterials using standardized preparation methods in both clinical and research scenarios. This step is critical to promote the comparison and allow a critical analysis of platelet-based therapies, allowing its development and rational clinical use.

show abstract

Section: The Boundaries Of Platelet Therapy: Mandatory Use Of Standar...mentioning

confidence: 99%

Regenerative Medicine in the Treatment of Traumatic Skin Wounds in Dogs and Cats Using Platelet-Rich Fibrin (PRF) Therapy

S. Soares,

P. Carvalho,

dos Anjos Pires

2024

Pearls in Biological and Molecular Tissue Repair Pathways

View full text Add to dashboard Cite

show abstract

“…Fibrin in PRP forms a tetramolecular bilateral connection, unfavorable for capturing GFs and cell migration. Previous studies show PRP fibrin networks are simple with premature fibers of smaller diameter (Dohan Ehrenfest et al, 2009), thus degrading faster than other APC with fewer GFs and leukocytes (Dohan Ehrenfest et al, 2009;Marin Fermin et al, 2023). However, the liquid state of PRP enables convenient combination with biomaterials.…”

Section: Platelet-rich Plasmamentioning

confidence: 99%

New strategy of personalized tissue regeneration: when autologous platelet concentrates encounter biomaterials

Ren,

Wang,

et al. 2023

Front. Bioeng. Biotechnol.

View full text Add to dashboard Cite

Components in blood play an important role in wound healing and subsequent tissue regeneration processes. The fibrin matrix and various bioactive molecules work together to participate in this complex yet vital biological process. As a means of personalized medicine, autologous platelet concentrates have become an integral part of various tissue regeneration strategies. Here, we focus on how autologous platelet concentrates play a role in each stage of tissue healing, as well as how they work in conjunction with different types of biomaterials to participate in this process. In particular, we highlight the use of various biomaterials to protect, deliver and enhance these libraries of biomolecules, thereby overcoming the inherent disadvantages of autologous platelet concentrates and enabling them to function better in tissue regeneration.

show abstract

Injection therapy in professional footballers

Jader,

Melo Cué,

Romandini

et al. 2024

International Orthopaedics (SICOT)

View full text Add to dashboard Cite

Review of Dohan Eherenfest et al. (2009) on “Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)”

Cited by 6 publications

References 44 publications

Regenerative Medicine in the Treatment of Traumatic Skin Wounds in Dogs and Cats Using Platelet-Rich Fibrin (PRF) Therapy

Regenerative Medicine in the Treatment of Traumatic Skin Wounds in Dogs and Cats Using Platelet-Rich Fibrin (PRF) Therapy

New strategy of personalized tissue regeneration: when autologous platelet concentrates encounter biomaterials

Injection therapy in professional footballers

Contact Info

Product

Resources

About